Stock Events

Cryo-Cell International 

$9.3
16
+$0.17+1.86% Today

Statistics

Day High
9.27
Day Low
9.01
52W High
9.5
52W Low
3.67
Volume
1,347
Avg. Volume
12,010
Mkt Cap
73.75M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

12JulExpected
Q3 2022
Q4 2022
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Next
-1.35
-0.82
-0.3
0.23
Expected EPS
0.04
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CCEL. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Services to the Health Industry
Health Services
Health Technology
Medical Specialties
Manufacturing
Dental Laboratories
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Show more...
CEO
Employees
82
Country
US
ISIN
US2288951088
WKN
000923368

Listings